Today, the EMA CHMP adopted a positive opinion recommending our Omicron BA.1-adapted #COVID19 vaccine booster, potentially providing Europeans with another solution to address the ongoing challenges of this disease: on.pfizer.com/3R6NT2p
@AlbertBourla | 58,047 followers
Replying to @AlbertBourla
Emergency uses of the Bivalent vaccine have not been approved or licensed by US FDA but have been authorized to prevent COVID-19 in ages 12yrs+. See Fact Sheets: cvdvaccine-us.com

Tweet Engagement Stats

Stats are based upon replies and quotes of this tweet

Engagement Map

Quotes
Replies
Retweets
Trendsmap

Replies and Quotes

Total of 5 replies and 2 quotes found
In reply to @AlbertBourla
Imagen you are 12+ and you parents decide you to protect with vaccine wich was tested on 8 mouses.. With no biodistribution, genotoxcity, cancrogenic studies would you be happy?
 
Tócate los 🥚🥚
¿Hace honor al apellido,eh?
 
In reply to @AlbertBourla
Surely their isn't new data to hide for 75 years?
 
In reply to @AlbertBourla
You put profit over people. People are learning how you lie and exploit them. pic.twitter.com/K6ZqGrpoFF
 
In reply to @DaniWolv
Y éste te dice en la cara lo que hay sin despeinarse. twitter.com/AlbertBourla/s…
 
Over 2 replies and quotes not shown

Retweeters

3 retweeters not shown
For access to this functionality a Trendsmap Explore subscription is required.

A Trendsmap Explore subscription provides full access to all available timeframes

Find out more

Thanks for trying our Trendsmap Pro demo.

For continued access, and to utliise the full functionality available, you'll need to subscribe to a Trendsmap Pro subscription.

Find out more

This account is already logged in to Trendsmap.
Your subscription allows access for one user. If you require access for more users, you can create additional subscriptions.
Please Contact us if you are interested in discussing discounts for 3+ users for your organisation, or have any other queries.